However, control CreERT2 B-ALL were largely unaffected by 4-OHT treatment, whereas Glut1 deletion led to a distinct metabolic profile in 4-OHT-treated Glut1fl/fl CreERT2 B-ALL cells (Figure 2a and Supplementary Table 1). Here, SLC2A1 is linked to acute lymphoblastic leukemia.